On Tuesday 16 December, the Cohort Coordination Board (CCB) celebrated its 40th meeting since it’s conception back in April 2022. The CCB, coordinated by the ID-CARE team at the University of Verona, is a forum that brings together cohort-based ID research projects across Europe alongside stakeholder representatives, aiming to facilitate partnerships, find solutions to common challenges
Longitudinal cohort studies, which follow individuals over time, are crucial for understanding disease progression, identifying risk factors, and evaluating public health interventions. END-VOC, one of the European Horizon projects funded during the COVID-19 pandemic, brought together 33 cohorts from 24 countries to study the impact of emerging variants on diagnostics, treatments and vaccines. The project contributed
At the end of September, members of the Cohort Coordination Board (CCB) headed to Rome, Italy, to join colleagues at the VERDI General Assembly and the first in-person workshop of the CCB. The week ended with a collaborative meeting between the CoMeCT and CONTAGIO project teams. VERDI Project General Assembly 2025On 23 and 24 September,
Last month, the second edition of the Cohort Coordination Board (CCB) Activity Report was published, providing a comprehensive overview of the Board’s activities and outputs between 1 January 2024 and 30 April 2025. An overview of the report was presented at the CCB’s first in-person workshop on 22 September in Rome, Italy. The CCB was
Following the 2022 mpox outbreak in Europe and it’s subsequent designation as a Public Health Emergency of International Concern (PHEIC), the Cohort Coordination Board (CCB) performed an extensive mapping of European mpox cohorts as per the VERDI and CoMeCT pandemic preparedness projects. Well-designed cohort studies are crucial for pandemic preparedness informing evidence-based infection prevention and treatment
Earlier this year the CoVICIS project, member of the Cohort Coordination Board, published the final outputs of the COVID Cohorts Policy Insight Series. These resources, listed at the end of this blog, summarise key policy insights from EU-funded COVID cohort consortia, informed by the CoVICIS-led policy project conducted between March 2024 through March 2025. Major
Today marks the launch of the Central Data Repository (CDR), the online database designed to support research pandemic preparedness efforts across Europe. Managed by the Cohort Coordination Board, the CDR offers a comprehensive collection of metadata from cohorts and trials across Europe focusing on infectious diseases with epidemic and pandemic potential. This resource is now publicly accessible
At the end of 2024 the Cohort Coordination Board (CCB) expanded its membership to include cohort studies targeting any infectious disease with epidemic or pandemic potential (IDEPP), welcoming five new cohorts of mpox: ITM Antwerp, MoVIHvax, German Mpox Cohort, VIHMIR, and MPOX-ICONA Cohort. See more information about these five cohorts below. German Mpox CohortThe German
Last week, Lorenzo Maria Canziani, from the ID-CARE Team at the University of Verona, attended the Demystifying Long COVID International Conference 2024, presenting the Cohort Coordination Board (CCB) and hosting an engaging networking event for the Board. The CCB, coordinated by the ID-CARE team at the University of Verona, is a forum that brings together cohort-based
Anna Gòrska from the ID-CARE Team at the University of Verona attended the 34thMedical Informatics Europe (MIE2024) Conference in Athens, Greece, on August 27th to present her work titled: Towards autonomous living meta-analyses: a framework for automation of systematic reviews and meta-analyses. The team has been working towards automating the systematic review and meta-analysis processes since the ValueDX
CoMeCT is hosting its first annual best practices workshop. Particular attention will be drawn to clinical operations, management and patient engagement through 5 insightful sessions featuring presentations from leading experts in the field. We will have the pleasure of being joined by Inge Christoffer Olsen (Oslo universitetssykehus ), Clare Relton (Queen Mary University of London),
The VEBIS network (Vaccine Effectiveness, Burden and Impact Studies), which joined the Cohort Coordination Board earlier this year, aims to provide technical support to the European Centre for Disease Prevention and Control to build an infrastructure to allow regular monitoring of COVID-19 and influenza vaccine effectiveness over time, using a multi-country approach. The VEBIS platform